0001415889-24-011390.txt : 20240423
0001415889-24-011390.hdr.sgml : 20240423
20240423180747
ACCESSION NUMBER: 0001415889-24-011390
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240419
FILED AS OF DATE: 20240423
DATE AS OF CHANGE: 20240423
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Yan Ming
CENTRAL INDEX KEY: 0001874041
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40632
FILM NUMBER: 24866221
MAIL ADDRESS:
STREET 1: C/O CYTEK BIOSCIENCES, INC.
STREET 2: 46107 LANDING PARKWAY
CITY: FREMONT
STATE: CA
ZIP: 94538
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cytek Biosciences, Inc.
CENTRAL INDEX KEY: 0001831915
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 472547526
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 47215 LAKEVIEW BOULEVARD
CITY: FREMONT
STATE: CA
ZIP: 94538
BUSINESS PHONE: (877) 922-9835
MAIL ADDRESS:
STREET 1: 47215 LAKEVIEW BOULEVARD
CITY: FREMONT
STATE: CA
ZIP: 94538
FORMER COMPANY:
FORMER CONFORMED NAME: Cytek BioSciences, Inc.
DATE OF NAME CHANGE: 20201110
4
1
form4-04232024_100439.xml
X0508
4
2024-04-19
0001831915
Cytek Biosciences, Inc.
CTKB
0001874041
Yan Ming
C/O CYTEK BIOSCIENCES, INC.
47215 LAKEVIEW BOULEVARD
FREMONT
CA
94538
true
true
false
false
CHIEF TECHNOLOGY OFFICER
1
Common Stock
2024-04-19
4
S
0
20000
5.87
D
5988502
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2023.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.75 to $5.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
/s/ Valerie Barnett, Attorney-in-Fact
2024-04-23